Clin2
NCT06547775Possibly a fitRecruiting

Study of KN069 for people with obesity or overweight

Overweight or Obesity

Part of Hormones & metabolism clinical trials.

This trial tests a new drug called KN069 to see if it can help people who are overweight or have obesity. It may offer a new treatment option for weight management.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be a man between 18 and 55 years old.
  • Your body mass index (BMI) must be between 24 and 35.
  • Your blood sugar levels must be in a specific range, and you cannot have diabetes.
  • You must be willing to follow the study rules and stay for the whole study.
  • You cannot have certain health conditions, like heart disease or pancreatitis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07224399Recruiting· Phase 1
Testing a new injection for weight loss in obesity

This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.

Baltimore, Maryland
NCT07274137Not yet recruiting· Phase 3
Weight-loss drug study for people with obesity or overweight

This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.

Beijing
NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT06911203Recruiting· Phase 2
Study of BGM0504 for people with obesity

This trial tests a new medicine called BGM0504 to help people with obesity lose weight. It may be an option if diet and exercise have not been enough and you qualify for a treatment study.

Beijing, Beijing Municipality
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de

Hear when a new Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.